Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L1 Health is the healthcare investment arm of LetterOne, an international investment business. The firm focuses on making long-term, large-scale investments in the global healthcare sector, targeting companies with strong growth potential and innovative technologies. L1 Health aims to build a diversified portfolio of healthcare assets, ranging from pharmaceuticals and biotechnology to medical devices and healthcare services. By leveraging its significant capital base and industry expertise, the firm supports its portfolio companies in scaling their operations and expanding their market presence globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L1 selected.